1. Cole LA. Biological functions of hCG and hCG-related molecules.Reproductive Biology and Endocrinology. 2010;8.
doi:10.1186/1477-7827-8-102
2. Beta-Human Chorionic Gonadotropin, Quantitative, Serum - Mayo Clinic
Laboratories | Neurology Catalog. Accessed January 1, 2023.
https://neurology.testcatalog.org/show/BHCG
3. Iles RK. Ectopic hCGβ expression by epithelial cancer: Malignant
behaviour, metastasis and inhibition of tumor cell apoptosis. Mol
Cell Endocrinol. 2007;260-262. doi:10.1016/j.mce.2006.02.019
4. Inoue N, Watanabe H, Takehara H, Hamazaki M, Kagami S. Refractory
pediatric nonrhabdomyosarcoma soft tissue sarcoma associated with
ectopic production of beta hCG and hypercalcemia induced by PTHrP.Pediatr Blood Cancer. 2011;57(7). doi:10.1002/pbc.23271
5. Pokharel K, Gilbar PJ, Mansfield SK, Nair LM, So A. Elevated beta
human chorionic gonadotropin in a non-pregnant female diagnosed with
anal squamous cell carcinoma. Journal of Oncology Pharmacy
Practice. 2020;26(5). doi:10.1177/1078155219893428
6. Das P, Crane CH, Eng C, Ajani JA. Prognostic factors for squamous
cell cancer of the anal canal. Gastrointest Cancer Res.
2008;2(1).
7. Key Statistics for Anal Cancer. Accessed January 1, 2023.
https://www.cancer.org/cancer/anal-cancer/about/what-is-key-statistics.html
8. Yao JN, Zhang XX, Zhou HN, et al. Human papillomavirus related anal
squamous cell carcinoma survival: A systematic review and meta-analysis.Transl Cancer Res. 2017;6(3). doi:10.21037/tcr.2017.06.13
9. Types of anal cancer | Cancer Research UK. Accessed January
1, 2023.
https://www.cancerresearchuk.org/about-cancer/anal-cancer/stages-types/types
10. Anal Cancer Screening for People at High Risk | OncoLink.
Accessed January 1, 2023.
https://www.oncolink.org/risk-and-prevention/prevention-screening/anal-cancer-screening
11. Anal Cancer Survival Rates. Accessed January 1, 2023.
https://www.cancer.org/cancer/anal-cancer/detection-diagnosis-staging/survival-rates.html
12. Schüler-Toprak S, Treeck O, Ortmann O. Human chorionic gonadotropin
and breast cancer. Int J Mol Sci. 2017;18(7).
doi:10.3390/ijms18071587
13. Ferreira AR, di Meglio A, Pistilli B, et al. Differential impact of
endocrine therapy and chemotherapy on quality of life of breast cancer
survivors: a prospective patient-reported outcomes analysis.Annals of Oncology. 2019;30(11). doi:10.1093/annonc/mdz298
14. Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase
inhibitors, and breast cancer. Journal of Steroid Biochemistry and
Molecular Biology. 2011;125(1-2). doi:10.1016/j.jsbmb.2011.02.001
15. Simpkins F, Garcia-Soto A, Slingerland J. New insights on the role
of hormonal therapy in ovarian cancer. In: Steroids. Vol 78. ;
2013. doi:10.1016/j.steroids.2013.01.008
16. Taberna M, Gil Moncayo F, Jané-Salas E, et al. The Multidisciplinary
Team (MDT) Approach and Quality of Care. Front Oncol. 2020;10.
doi:10.3389/fonc.2020.00085